Active, Not Recruiting DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL NCT03620578 Conditions BCL-2 Translocation, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more Locations BE-Antwerpen-ZNASTUIVENBERG — Antwerp, Belgium BE-Leuven-UZLEUVEN — Leuven, Belgium NL-Den Bosch-JBZ — 's-Hertogenbosch, Netherlands NL-Almere-FLEVOZIEKENHUIS — Almere Stad, Netherlands View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
